LINCOLN PHARMACEUTICALS
Back to Balance Sheet
|
LINCOLN PHARMACEUTICALS Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹586 Cr | ₹507 Cr | ₹418 Cr | ₹348 Cr | ₹282 Cr |
What is the latest Profit & Loss Account Balance ratio of LINCOLN PHARMACEUTICALS ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2025 | ₹586 Cr |
| Mar2024 | ₹507 Cr |
| Mar2023 | ₹418 Cr |
| Mar2022 | ₹348 Cr |
| Mar2021 | ₹282 Cr |
How is Profit & Loss Account Balance of LINCOLN PHARMACEUTICALS Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2025 | ₹586 Cr | 15.42 | |
| Mar2024 | ₹507 Cr | 21.50 | |
| Mar2023 | ₹418 Cr | 19.93 | |
| Mar2022 | ₹348 Cr | 23.32 | |
| Mar2021 | ₹282 Cr | - | |
Compare Profit & Loss Account Balance of peers of LINCOLN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LINCOLN PHARMACEUTICALS | ₹1,223.8 Cr | -1.2% | 5.2% | 13% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹458,249.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,891.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹115,927.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
LINCOLN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LINCOLN PHARMACEUTICALS | -1.2% |
5.2% |
13% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses